期刊文献+

2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺的合成工艺研究

Study on the Synthesis of 2-methoxy-3-(1-methyl-1H-1,2,4-triazole-3-yl)Aniline
下载PDF
导出
摘要 目的研究2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺的合成工艺。方法以2-羟基-3-硝基苯甲酸甲酯为原料经两步取代得到2-甲氧基-3-硝基苯甲酰胺(3),3与劳森试剂反应制得2-甲氧基-3-硝基苯并硫代酰胺(7),7与碘甲烷反应制得2-甲氧基-3-硝基苯并亚氨基硫代甲酸甲酯(8),8与1-甲基肼甲酸叔丁酯反应制得2-(亚氨基(2-甲氧基-3-硝基苯基)甲基)-1-甲基肼甲酸叔丁酯(9),9经取代,还原得到目标化合物2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺。结果目标化合物总收率为45.8%,结构经1H NMR和MS表征确证。结论本合成工艺各步反应条件温和易操作,后处理简单,降低了原料成本,增加了反应稳定性,可为工业化生产提供参考。 Objective To study the synthesis of 2-methoxy-3-(1-methyl-1 H-1,2,4-triazole-3-yl)aniline.Methods 2-Methoxy-3-nitrobenzoate acid methyl ester was used as a raw material to synthesize 2-methoxy-3-nitrobenzamide(3)by two-step substitution,and 3 was reacted with Lawson’s reagent to obtain 2-methoxy-3-nitrobenzothioamide(7),7 reacts with methyl iodide to obtain methyl 2-methoxy-3-nitrobenzoiminothioformate(8),8 and 1-methyl Tert-Butyl hydrazine formate was prepared to give 2-(imino(2-methoxy-3-nitrophenyl)methyl)-1-methyl tert-butyl hydrazine(9),9 was substituted and reduced.The target compound was 2-methoxy-3-(1-methyl-1 H-1,2,4-triazole-3-yl)aniline.Results The total yield of the target compound was 45.8%and the structure was characterized by 1 H NMR and MS.Conclusion The reaction conditions of each step in the synthesis process are mild and easy to operate,the post-treatment is simple,the cost of raw materials is reduced,the reaction stability is increased,and it can provide a reference for industrial production.
作者 陈梦雅 吴诗 CHEN Meng-Ya;WU Shi(School of Pharmacy,Hubei University of Science and Technology,Xianning Hubei 437100,China)
出处 《湖北科技学院学报(医学版)》 2020年第4期293-295,301,共4页 Journal of Hubei University of Science and Technology(Medical Sciences)
基金 湖北科技学院2017年度校内培育科研项目资助(2018-19X014) 湖北科技学院药学院2018年度药学重点学科专项科研项目资助(2019-20ZY16)。
关键词 2-甲氧基-3-(1-甲基-1H-1 2 4-三唑-3-基)苯胺 TYK2变构抑制剂 合成工艺 2-methoxy-3-(1-methyl-1H-1 2 4-triazole-3-yl)aniline TYK2 allosteric inhibitor Synthesis
  • 相关文献

参考文献2

二级参考文献32

  • 1Galeazi M,Gasbarrini G,Ghirardello A,et al.Autoinflammatory syndromes[J].Clin Exp Rheumatol,2006,24:79-85.
  • 2Doria A,Zen M,Bettio S,et al.Autoinflammation and autoimmunity:Bridging the divide[J].Autoimmunity Reviews,2012,12:22-30.
  • 3Federici S,Caorsi R,Gattorno M.The autoinflammatory diseases[J].Swiss Med Wkly,2012,142:w13602.
  • 4Yao Q,Su LC,Tomechi KJ,et al.Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations[J].J Am Acad Dermatol,2013,68:624-631.
  • 5Borghini S,Tassi S,Chiesa S,et al.Clinical presentation and pathogenesis of cold-induced autoinfammatory disease in a family with recurrence of an NLRP12 mutation[J].Arthritis Rheum,2011,63:830-839.
  • 6Theofilopouos AN,Gonzalez-Quintial R,Lawson BR,et al.Sensors of the immune system:their link to rheumatic diseases[J].Nat Rev Rheumatol,2010,6:146-156.
  • 7Pineton de Chambrun M,Wechsler B,Geri G,et al.New insights into the pathogenesis of Behet’s disease[J].Autoimmun Rev,2012,11:687-698.
  • 8Martinon F,Burns K,Tschopp J.The inflammasome:a molecular platform triggering activation of inflammatory caspases and processing of pro IL-beta[J].Mol Cell,2002,10:417-426.
  • 9Zen M,Gatto M,Domeneghetti M,et al.Clinical guidelines and definitions of autoinflammatory diseases:contrasts and omparisons with autoimmunity—a comprehensive review[J].Clinic Rev Allerg Immunol,2013,45:227-235.
  • 10Cho JH,Gregersen PK.Genomics and the multifactorial nature of human autoimmune disease[J].N Eng J Med 2011,365:1612-1623.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部